SynthesisCardiovascular toxicology2025

A Meta-analysis of the Risk of Adverse Cardiovascular Events in Patients with Cancer Treated with Inhibitors of the PI3K/AKT/mTOR Signaling Pathway.

Xiao Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.